Drugs / solasodine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04693000 | Sep 2018 → Jan 2021 | — | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | solasodine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04693000 ↗ |
| Modality | Small molecule | — CHEMBL514596 ↗ |
| Route | Topical | “An ointment containing solasodine extract of solanum melongena peel origin applied to patients with palmar arsenical keratosis” NCT04693000 ↗ |